A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report

BACKGROUND: Germline BRCA2 mutation is associated with an aggressive prostate cancer phenotype and indicates higher risk for hereditary cancer. Recently, numerous studies have attempted to identify the genomic landscape of prostate cancer to better understand the genomic drivers of this disease and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lijuan, Bai, Zunguang, Zhu, Shoulun, Zhao, Tingting, Yang, Yining, Li, Zhiyong, Chen, Dong, Wu, Zhiming, Wang, Yanjun, Zhou, Fangjian, Li, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381549/
https://www.ncbi.nlm.nih.gov/pubmed/34425813
http://dx.doi.org/10.1186/s12894-021-00879-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381549/
https://www.ncbi.nlm.nih.gov/pubmed/34425813
http://dx.doi.org/10.1186/s12894-021-00879-4

Ejemplares similares